242 related articles for article (PubMed ID: 25581729)
1. Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.
Gronchi A; Collini P; Miceli R; Valeri B; Renne SL; Dagrada G; Fiore M; Sanfilippo R; Barisella M; Colombo C; Morosi C; Stacchiotti S; Casali PG; Dei Tos AP; Pilotti S
Am J Surg Pathol; 2015 Mar; 39(3):383-93. PubMed ID: 25581729
[TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.
Mussi C; Collini P; Miceli R; Barisella M; Mariani L; Fiore M; Casali PG; Gronchi A
Cancer; 2008 Oct; 113(7):1657-65. PubMed ID: 18704991
[TBL] [Abstract][Full Text] [Related]
3. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
4. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
[TBL] [Abstract][Full Text] [Related]
5. Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.
Keung EZ; Hornick JL; Bertagnolli MM; Baldini EH; Raut CP
J Am Coll Surg; 2014 Feb; 218(2):206-17. PubMed ID: 24315890
[TBL] [Abstract][Full Text] [Related]
6. Resectable well-differentiated versus dedifferentiated liposarcomas: two different diseases possibly requiring different treatment approaches.
Lahat G; Anaya DA; Wang X; Tuvin D; Lev D; Pollock RE
Ann Surg Oncol; 2008 Jun; 15(6):1585-93. PubMed ID: 18398663
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.
Jour G; Gullet A; Liu M; Hoch BL
Mod Pathol; 2015 Jan; 28(1):37-47. PubMed ID: 25059573
[TBL] [Abstract][Full Text] [Related]
8. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
Liu L; Wang LH; Ren YB; Rao XS; Yang SM
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
[No Abstract] [Full Text] [Related]
9. Retroperitoneal Dedifferentiated Liposarcoma.
Dehner CA; Hagemann IS; Chrisinger JSA
Am J Clin Pathol; 2021 Oct; 156(5):920-925. PubMed ID: 34125170
[TBL] [Abstract][Full Text] [Related]
10. Correlation of histological grade of dedifferentiation with clinical outcome in 55 patients with dedifferentiated liposarcomas.
Dantey K; Schoedel K; Yergiyev O; Bartlett D; Rao UNM
Hum Pathol; 2017 Aug; 66():86-92. PubMed ID: 28300575
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades--a clinicopathologic study of 32 cases.
Hasegawa T; Seki K; Hasegawa F; Matsuno Y; Shimodo T; Hirose T; Sano T; Hirohashi S
Hum Pathol; 2000 Jun; 31(6):717-27. PubMed ID: 10872666
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).
Nessim C; Raut CP; Callegaro D; Barretta F; Miceli R; Fairweather M; Blay JY; Strauss D; Rutkowski P; Ahuja N; Gonzalez R; Grignani G; Quagliuolo V; Stoeckle E; Lahat G; De Paoli A; Pillarisetty VG; Canter RJ; Mullen JT; Pennacchioli E; van Houdt W; Swallow CJ; Schrage Y; Cardona K; Fiore M; Gronchi A; Bagaria SP
Ann Surg Oncol; 2021 Nov; 28(12):7854-7863. PubMed ID: 33907921
[TBL] [Abstract][Full Text] [Related]
13. Primary retroperitoneal liposarcoma: clinical and histological analysis of ten cases.
Fernández-Ruiz M; Rodríguez-Gil Y; Guerra-Vales JM; Manrique-Municio A; Moreno-González E; Colina-Ruizdelgado F
Gastroenterol Hepatol; 2010 May; 33(5):370-6. PubMed ID: 20206410
[TBL] [Abstract][Full Text] [Related]
14. Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection.
Gronchi A; Miceli R; Allard MA; Callegaro D; Le Péchoux C; Fiore M; Honoré C; Sanfilippo R; Coppola S; Stacchiotti S; Terrier P; Casali PG; Le Cesne A; Mariani L; Colombo C; Bonvalot S
Ann Surg Oncol; 2015 May; 22(5):1447-54. PubMed ID: 25300609
[TBL] [Abstract][Full Text] [Related]
15. Dedifferentiation within well-differentiated liposarcoma of the extremity or trunk: Implications for clinical management.
Tseng WW; Barretta F; Baia M; Barisella M; Radaelli S; Callegaro D; Yoon DH; Fiore M; Gronchi A
J Surg Oncol; 2021 Oct; 124(5):838-845. PubMed ID: 34254688
[TBL] [Abstract][Full Text] [Related]
16. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
17. Histologic type predicts survival in patients with retroperitoneal soft tissue sarcoma.
Tseng W; Martinez SR; Tamurian RM; Borys D; Canter RJ
J Surg Res; 2012 Jan; 172(1):123-30. PubMed ID: 20869082
[TBL] [Abstract][Full Text] [Related]
18. Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?
Tseng WW; Madewell JE; Wei W; Somaiah N; Lazar AJ; Ghadimi MP; Hoffman A; Pisters PW; Lev DC; Pollock RE
Ann Surg Oncol; 2014 Jul; 21(7):2136-43. PubMed ID: 24705628
[TBL] [Abstract][Full Text] [Related]
19. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
[TBL] [Abstract][Full Text] [Related]
20. Are peripheral purely undifferentiated pleomorphic sarcomas with MDM2 amplification dedifferentiated liposarcomas?
Le Guellec S; Chibon F; Ouali M; Perot G; Decouvelaere AV; Robin YM; Larousserie F; Terrier P; Coindre JM; Neuville A
Am J Surg Pathol; 2014 Mar; 38(3):293-304. PubMed ID: 24525499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
